Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

421

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo

Fasiglifam placebo-matching tablets

DRUG

Fasiglifam

Fasiglifam tablets

Trial Locations (95)

Unknown

Dothan

Muscle Shoals

Goodyear

Phoenix

Long Beach

North Hollywood

Norwalk

Palm Springs

Pismo Beach

Boynton Beach

Bradenton

Coral Gables

Hialeah

Largo

New Port Richey

Orlando

Pembroke Pines

Decatur

Chicago

Avon

Greenfield

Muncie

Council Bluffs

Topeka

Lexington

Oxon Hill

Flint

Picayune

Omaha

Elizabeth

Charlotte

Greensboro

Mooresville

Morganton

Raleigh

Maumee

Oklahoma City

Harleysville

Levittown

Uniontown

Greer

Crossville

Carrollton

Dallas

El Pasco

Fort Worth

Houston

Irving

New Braunfels

San Antonio

Spring

Tomball

Salt Lake City

Burke

Manassas

Buenos Aires

Ciudad Autonoma Buenos Aires

Corrientes

Córdoba

Villa Cabrera

Mendoza

Byala

Plovdiv

Rousse

Sofia

Varna

Guatemala City

Quetzaltenango

Zacapa

Budapest

Debrecen

Kecskemét

Komárom

Szikszó

Zalaegerszeg

Mexico City

Monterrey

Banská Bystrica

Bratislava

Dolný Kubín

Komárno

Levice

Pezinok

Prievidza

Trebišov

Trenčín

Žilina

Dnipropetrovsk

Kharkiv

Kyiv

Odesa

Simferopol

Ternopil

Vinnytsia

Zaporizhzhia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY